Here, we used genetic mapping, kidney eQTL and mQTL, single-cell open chromatin information, and advanced statistical methods such as Bayesian colocalization, Mendelian randomization, and chromatin coaccessibility methods to prioritize ACSS2 as a kidney disease risk gene on chromosome 20. The gene discussed is ACSS2; the disease is kidney disorder.